TFX
Teleflex·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TFX
Teleflex Incorporated
A leading global provider of medical technologies for critical care and surgery
Healthcare Equipment and Supplies
--
04/28/1994
New York Stock Exchange
14,100
12-31
Common stock
550 East Swedesford Road, Suite 400, Wayne, Pennsylvania 19087
--
Teleflex Incorporated is a Delaware corporation founded in 1943. The company is a global supplier of medical technology products that increase clinical benefit, improve patient and provider safety, and reduce total procedure costs. The Company primarily designs, develops, manufactures and supplies disposable medical devices for use by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells products to hospitals and healthcare providers around the world through a combination of direct sales force and distributors.
Earnings Call
Company Financials
EPS
TFX has released its 2025 Q3 earnings. EPS was reported at 3.67, versus the expected 3.38, beating expectations. The chart below visualizes how TFX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TFX has released its 2025 Q3 earnings report, with revenue of 913.02M, reflecting a YoY change of 19.45%, and net profit of -408.89M, showing a YoY change of -468.36%. The Sankey diagram below clearly presents TFX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



